Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
20.0%
% of PJP's 30 holdings also in PBE
21.4%
% of PBE's 28 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 5.2% | 5.1% | 5.1% |
|
AMGEN INC | 5.0% | 5.0% | 5.0% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 2.9% | 2.9% | 2.9% |
|
BIOGEN IDEC INC | 2.7% | 5.0% | 2.7% |
|
REGENERON PHARMACEUTICALS | 2.5% | 4.5% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to PBE
|
ABBVIE INC | 5.2% |
|
JOHNSON & JOHNSON | 5.1% |
|
MERCK & CO. INC. | 5.0% |
|
ABBOTT LABORATORIES | 5.0% |
|
PFIZER INC | 4.9% |
|
ELI LILLY & CO | 4.7% |
|
TARSUS PHARMACEUTICALS, INC. | 3.5% |
|
BIOSANTE PHARMACEUTICALS INC | 3.5% |
 |
PERRIGO CO | 3.1% |
|
BRISTOL-MYERS SQUIBB CO | 2.9% |
PJP Underweight Relative to PBE
|
NEUROCRINE BIOSCIENCES INC | -5.0% |
|
NATERA INC | -4.7% |
|
ILLUMINA INC | -4.3% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.9% |
|
TG THERAPEUTICS INC | -3.8% |
|
CATALYST PHARMACEUTICAL PART | -3.3% |
|
HALOZYME THERAPEUTICS INC | -3.1% |
|
PTC THERAPEUTICS INC | -3.0% |
|
DYNAVAX TECHNOLOGIES CORP | -2.9% |
|
BIOMARIN PHARMACEUTICAL INC | -2.8% |